HORSHAM, Pa., March 23, 2015 /PRNewswire/ — Flower Orthopedics Corporation (Flower Orthopedics) today announced that it has successfully completed a $4.5 million Series C equity raise. Proceeds from the financing will be used for working capital and to fund the company’s growth strategies.
Flower Orthopedics is the creator of the FlowerCube™, a standardized, single-use bone fixation concept that provides significant operational efficiencies. The FlowerCube™ is tailored for specific orthopedic surgical indications, and houses all of the requisite implants and instruments sterile packaged and disposable eliminating pre-operative on-site sterilization. Guaranteed pristine, and always complete Flower’s Ready-for-Surgery™ instruments provide assurance that the right surgery specific tools are in place and in prime condition. Due to its sterile and disposable nature, The FlowerCube™ is always ready for the next surgery, allowing for a faster OR turnaround and increased back to back surgical cases.
“The financial resources provided by the Series C equity raise continue to bring our FlowerCube™ concept to more hospitals and ambulatory surgery centers across the United States,” said Oliver Burckhardt, President and CEO of Flower Orthopedics. “We are excited to present physicians with the Ready-for-Surgery Flowercube™ that will simplify surgical processes, provide operational efficiencies and could potentially decrease patient recovery time.”
“Flower Orthopedics has been a success story from the beginning and we believe it will make a significant impact in the orthopedics industry. It is gratifying to watch the market respond so positively to this innovative, total surgical solution,” added George Jenkins, Flower Orthopedics Board Member from Merritt Capital Corporation.
